A slide from a study titled "A multimeter Randomized Double-Blind Placebo-Controlled Parallel-Group Study Comparing the Efficiency and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 vs Placebo for the Preventive Treatment of Epidemic Migraine". The slide has a light blue background with a white snowflake design on the top right corner. The title of the study is written in bold black font at the top of the slide. Below the title there is a table with three columns. The first column is titled "Primary Outcome Measures" and the second column is labeled "Secondary Outcome Measurements". The table is divided into two sections. The second section has a list of primary outcome measures the third section has the primary outcome measure and the fourth section has two secondary outcome measures. The table also has a brief description of each measure. At the bottom of the page there are two bullet points that explain the study's purpose and how it can be used to compare the efficacy and safety of two dose regimens of subcutaneous administration of TEv 48125 and placebo for the preventive treatment of episodic migraine.

• Advertisement

• Outreach and Education